Product Information
AMLODIPINE-OLMESARTAN 10-40 MG is a generic product labeled by Ascend Laboratories, LLC, priced at $0.3161 per EA under NDC 67877050290. Its NADAC has been published 420 times since Aug 8, 2018.
FDA first approved this application on Aug 14, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10; 40 mg/1; mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877050290
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA209042FDA Approved
8/14/2017
TE Code
AB
On Market Since
8/14/2017
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-OLMESARTAN 10-40 MG has been published 420 times since Aug 8, 2018, and over the history we have for it it has declined 61.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3161 per EA |
|---|---|
| All-time high | $0.8711 (Jan 15, 2020) |
| All-time low | $0.2641 (Jan 17, 2024) |
| 52-week high | $0.3755 |
| 52-week low | $0.3156 |
| Median price | $0.4364 |
| Average price | $0.5032 |
| Largest weekly change | +47.0% (Nov 22, 2023) |
| Weeks tracked | 420 |
| Tracking since | Aug 8, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMLODIPINE-OLMESARTAN 10-40 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 10-40 MG, manufactured by Ascend Laboratories, LLC, is $0.3161 per EA (NDC 67877050290), effective Aug 19, 2026.
How has the price of AMLODIPINE-OLMESARTAN 10-40 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 10-40 MG has declined 61.4%. It has been tracked across 420 weekly CMS publications since Aug 8, 2018.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 10-40 MG?
Since Aug 8, 2018, the NADAC for AMLODIPINE-OLMESARTAN 10-40 MG has ranged from a low of $0.2641 (Jan 17, 2024) to a high of $0.8711 (Jan 15, 2020), with a median of $0.4364 per EA.
Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 10-40 MG?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-OLMESARTAN 10-40 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures AMLODIPINE-OLMESARTAN 10-40 MG?
AMLODIPINE-OLMESARTAN 10-40 MG (NDC 67877050290) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.